Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Feb;59(2):391–397.

Interferon-gamma production by peripheral blood leucocytes from patients with multiple sclerosis and other neurological diseases.

G Vervliet, H Carton, A Billiau
PMCID: PMC1577129  PMID: 3919978

Abstract

Peripheral blood leucocyte (PBL) cultures of patients with meningoencephalitis, myasthenia gravis, Alzheimer's dementia, Huntington's chorea as well as patients who were recovering from cerebrovascular accidents or from craniotomy for brain tumours, all had defective interferon-gamma (IFN-gamma) responses to stimulation with concanavalin A (Con A) and phytohaemagglutinin (PHA), similar to those already described for PBL cultures of patients with multiple sclerosis. Specifically, cultures from a significant percentage of the patients failed to produce IFN after stimulation with either of the two mitogens. The yields from those cultures that did respond were not significantly lower than those from cultures of healthy blood donors. With increased doses of Con A, the cerebrovascular accident, meningo-encephalitis and MS groups kept their low response frequencies, while the other groups, i.e., myasthenia gravis, Alzheimer's dementia, Huntington's chorea and post-craniotomy, developed an increased response frequency. A good concordance was found between responsiveness to Con A and PHA. With pokeweed mitogen (PWM) as an inducer, no reduction in response frequencies or IFN yields were seen in any of the patient groups. Also, in general, yields were higher with PWM than with Con A.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besedovsky H., Sorkin E. Network of immune-neuroendocrine interactions. Clin Exp Immunol. 1977 Jan;27(1):1–12. [PMC free article] [PubMed] [Google Scholar]
  2. Bloom B. R. Interferons and the immune system. Nature. 1980 Apr 17;284(5757):593–595. doi: 10.1038/284593a0. [DOI] [PubMed] [Google Scholar]
  3. Brooks W. H., Netsky M. G., Normansell D. E., Horwitz D. A. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor. J Exp Med. 1972 Dec 1;136(6):1631–1647. doi: 10.1084/jem.136.6.1631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dropcho E. J., Richman D. P., Antel J. P., Arnason B. G. Defective mitogenic responses in myasthenia gravis and multiple sclerosis. Ann Neurol. 1982 May;11(5):456–462. doi: 10.1002/ana.410110504. [DOI] [PubMed] [Google Scholar]
  5. Gyódi E., Benczur M., Pálffy G., Tálas M., Petrányi G., Földes I., Hollán S. R. Association between HLA B7, DR2 and dysfunction of natural- and antibody-mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis. Hum Immunol. 1982 Jun;4(3):209–217. doi: 10.1016/0198-8859(82)90036-2. [DOI] [PubMed] [Google Scholar]
  6. Kurtzke J. F. Neurologic impairment in multiple sclerosis and the disability status scale. Acta Neurol Scand. 1970;46(4):493–512. doi: 10.1111/j.1600-0404.1970.tb05808.x. [DOI] [PubMed] [Google Scholar]
  7. Miller A. E., Neighbour P. A., Katzman R., Aronson M., Lipkowitz R. Immunological studies in senile dementia of the Alzheimer type: evidence for enhanced suppressor cell activity. Ann Neurol. 1981 Dec;10(6):506–510. doi: 10.1002/ana.410100603. [DOI] [PubMed] [Google Scholar]
  8. Neighbour P. A., Miller A. E., Bloom B. R. Interferon responses of leukocytes in multiple sclerosis. Neurology. 1981 May;31(5):561–566. doi: 10.1212/wnl.31.5.561. [DOI] [PubMed] [Google Scholar]
  9. Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T cells in active multiple sclerosis. Analysis with monoclonal antibodies. N Engl J Med. 1980 Jul 17;303(3):125–129. doi: 10.1056/NEJM198007173030303. [DOI] [PubMed] [Google Scholar]
  10. SCHUMACHER G. A., BEEBE G., KIBLER R. F., KURLAND L. T., KURTZKE J. F., MCDOWELL F., NAGLER B., SIBLEY W. A., TOURTELLOTTE W. W., WILLMON T. L. PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS. Ann N Y Acad Sci. 1965 Mar 31;122:552–568. doi: 10.1111/j.1749-6632.1965.tb20235.x. [DOI] [PubMed] [Google Scholar]
  11. Salonen R., Ilonen J., Reunanen M., Nikoskelainen J., Salmi A. PPD-, PWM-, and PHA-induced interferon in stable multiple sclerosis: association with HLA-Dw2 antigen and clinical variables. Ann Neurol. 1982 Mar;11(3):279–284. doi: 10.1002/ana.410110308. [DOI] [PubMed] [Google Scholar]
  12. Salonen R., Ilonen J., Reunanen M., Salmi A. Defective production of interferon-alpha associated with HLA-DW2 antigen in stable multiple sclerosis. J Neurol Sci. 1982 Aug;55(2):197–206. doi: 10.1016/0022-510x(82)90101-0. [DOI] [PubMed] [Google Scholar]
  13. Shore A., Limatibul S., Dosch H. M., Gelfand E. W. Identification of two serum components regulating the expression of T-lymphocyte function in childhood myasthenia gravis. N Engl J Med. 1979 Sep 20;301(12):625–629. doi: 10.1056/NEJM197909203011202. [DOI] [PubMed] [Google Scholar]
  14. Tovell D. R., McRobbie I. A., Warren K. G., Tyrrell D. L. Interferon production by lymphocytes from multiple sclerosis and non-MS patients. Neurology. 1983 May;33(5):640–643. doi: 10.1212/wnl.33.5.640. [DOI] [PubMed] [Google Scholar]
  15. Vervliet G., Carton H., Meulepas E., Billiau A. Interferon production by cultured peripheral leucocytes of MS patients. Clin Exp Immunol. 1984 Oct;58(1):116–126. [PMC free article] [PubMed] [Google Scholar]
  16. Vervliet G., Claeys H., Van Haver H., Carton H., Vermylen C., Meulepas E., Billiau A. Interferon production and natural killer (NK) activity in leukocyte cultures from multiple sclerosis patients. J Neurol Sci. 1983 Jul;60(1):137–150. doi: 10.1016/0022-510x(83)90133-8. [DOI] [PubMed] [Google Scholar]
  17. Wolfe J. H., Saporoschetz I., Young A. E., O'Connor N. E., Mannick J. A. Suppressive serum, suppressor lymphocytes, and death from burns. Ann Surg. 1981 Apr;193(4):513–520. [PMC free article] [PubMed] [Google Scholar]
  18. Zilko P. J., Dawkins R. L., Holmes K., Witt C. Genetic control of suppressor lymphocyte function in myasthenia gravis: relationship of impaired suppressor function to HLA-B8/DRW3 and cold reactive lymphocytotoxic antibodies. Clin Immunol Immunopathol. 1979 Oct;14(2):222–230. doi: 10.1016/0090-1229(79)90143-0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES